BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 21620077)

  • 1. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
    Abate D; Cesaro S; Cofano S; Fiscon M; Saldan A; Varotto S; Mengoli C; Pillon M; Calore E; Biasolo MA; Cusinato R; Barzon L; Messina C; Carli M; Palù G
    Transplantation; 2012 Mar; 93(5):536-42. PubMed ID: 22314338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
    Puchhammer-Stöckl E; Görzer I; Zoufaly A; Jaksch P; Bauer CC; Klepetko W; Popow-Kraupp T
    Transplantation; 2006 Jan; 81(2):187-94. PubMed ID: 16436961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients.
    Chiereghin A; Gabrielli L; Zanfi C; Petrisli E; Lauro A; Piccirilli G; Baccolini F; Dazzi A; Cescon M; Morelli MC; Pinna AD; Landini MP; Lazzarotto T
    Transplant Proc; 2010; 42(1):69-73. PubMed ID: 20172283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus DNA load patterns developing after lung transplantation are significantly correlated with long-term patient survival.
    Kerschner H; Jaksch P; Karigl G; Popow-Kraupp T; Klepetko W; Puchhammer-Stöckl E
    Transplantation; 2009 Jun; 87(11):1720-6. PubMed ID: 19502966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation.
    Costa C; Delsedime L; Solidoro P; Curtoni A; Bergallo M; Libertucci D; Baldi S; Rinaldi M; Cavallo R
    Transplant Proc; 2010 May; 42(4):1270-4. PubMed ID: 20534278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
    Lochmanova A; Lochman I; Tomaskova H; Marsalkova P; Raszka J; Mrazek J; Dedochova J; Martinek A; Brozmanova H; Grundmann M
    Transplant Proc; 2010 Nov; 42(9):3574-7. PubMed ID: 21094818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
    Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.
    Abate D; Saldan A; Fiscon M; Cofano S; Paciolla A; Furian L; Ekser B; Biasolo MA; Cusinato R; Mengoli C; Bonfante L; Rossi B; Rigotti P; Sgarabotto D; Barzon L; Palù G
    J Infect Dis; 2010 Aug; 202(4):585-94. PubMed ID: 20594105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    J Infect Dis; 2004 Sep; 190(6):1076-83. PubMed ID: 15319856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients.
    Schlischewsky E; Fuehner T; Warnecke G; Welte T; Haverich A; Ganzenmueller T; Heim A; Gottlieb J
    Transpl Infect Dis; 2013 Feb; 15(1):60-9. PubMed ID: 23025532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
    Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis.
    Wiita AP; Roubinian N; Khan Y; Chin-Hong PV; Singer JP; Golden JA; Miller S
    Transpl Infect Dis; 2012 Jun; 14(3):248-58. PubMed ID: 22385394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis.
    Solidoro P; Patrucco F; Libertucci D; Verri G; Sidoti F; Curtoni A; Boffini M; Simonato E; Rinaldi M; Cavallo R; Costa C
    Ther Adv Respir Dis; 2019; 13():1753466619878555. PubMed ID: 31566097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis and effective treatment of pulmonary CMV infection after lung transplantation.
    Steinhoff G; Behrend M; Wagner TO; Höper MH; Haverich A
    J Heart Lung Transplant; 1991; 10(1 Pt 1):9-14. PubMed ID: 1848789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lack of cytomegalovirus-specific cellular immune response may contribute to the onset of organ infection and disease in lung transplant recipients.
    Costa C; Saldan A; Sinesi F; Sidoti F; Balloco C; Simeone S; Piceghello A; Mantovani S; Di Nauta A; Solidoro P; Cavallo R
    Int J Immunopathol Pharmacol; 2012; 25(4):1003-9. PubMed ID: 23298490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.